Industry Research Reports
Home > Reports > Service & Software > Global GMP-grade AAV Vector Manufacturing Service Market Research Report 2026
Global GMP-grade AAV Vector Manufacturing Service Market Research Report 2026
Industry: Service & Software
Published Date: 2026-07-18
Pages: 129 Pages
Report ld: 6978179
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
GMP-grade AAV Vector Manufacturing Service Market Size(US$)
CAGR 2026-2032
13.2%
Market Size,2032
USD 2,060
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 979 million
Market Forecast in 2032(Value)
US$ 2,060 million
CAGR
13.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global GMP-grade AAV Vector Manufacturing Service market was valued at US$ 865 million in 2025 and is anticipated to reach US$ 2060 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
GMP-grade AAV vector manufacturing services refer to contract development and manufacturing activities performed under pharmaceutical good manufacturing practice requirements for recombinant adeno-associated viral vectors. The service scope generally includes process development, cell-bank establishment, GMP drug-substance manufacturing, purification, formulation, sterile filtration, fill and finish, quality testing, stability studies, batch release and regulatory support. Common production routes include adherent or suspension HEK293 transient transfection, stable producer-cell platforms and baculovirus-Sf9 systems. Key upstream inputs include GMP-grade transfer plasmids, Rep/Cap plasmids, helper plasmids, production cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables, single-use bioreactors and analytical reagents. Major downstream customers include gene therapy developers, biotechnology companies, pharmaceutical companies, hospital translational platforms and research institutions, with applications covering IND submissions, clinical trials, process validation and commercial supply. The industry's overall gross margin is generally estimated at approximately 25%-40%.
The global market currently consists of large integrated CDMOs, specialized AAV manufacturers and regional cell and gene therapy service providers. Large CDMOs compete through global quality systems, multi-site manufacturing networks, commercial-batch experience and integrated fill-and-finish capabilities. Specialized AAV providers differentiate themselves through high-yield HEK293 cells, proprietary plasmid systems, capsid technologies and dedicated AAV facilities. Chinese and other Asia-Pacific providers compete primarily through cost, delivery speed, early-clinical project experience and integrated service offerings. Because clinical programs require consistent technology transfer, comparability, stability data and regulatory documentation, changing suppliers after a program enters GMP manufacturing is substantially more difficult than switching research-grade packaging vendors.
Demand growth is supported by the progression of AAV gene therapy programs into clinical development, indication expansion for approved products, tissue-specific capsid development and increasing outsourcing by small and mid-sized biotechnology companies. Neurological, ophthalmic, neuromuscular and rare metabolic diseases remain important sources of GMP projects, while dual-AAV systems, engineered capsids and gene-editing delivery create additional process-development requirements. Growth is becoming less dependent on the total number of discovery programs and more dependent on whether candidates reach IND submission, advance into later-stage trials and generate repeat manufacturing orders. Tightening expectations for product quality, manufacturing consistency, potency assays and comparability favor providers with integrated analytical, quality and regulatory capabilities.
Manufacturing technology is gradually shifting from adherent culture and highly customized workflows toward suspension culture, platform processes and stable producer-cell systems. Suspension HEK293 transient transfection remains the principal route for clinical-scale expansion, but plasmid and transfection-reagent costs, batch variability and scale-up complexity remain significant. Stable producer cells, dual-plasmid systems, baculovirus-Sf9 platforms and plasmid-free technologies may lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward enrichment of full capsids, removal of empty and partially packaged particles and tighter control of host-cell DNA, host-cell proteins, residual plasmids and replication-competent AAV.
The main constraints include gene therapy financing and pipeline reprioritization, underutilized GMP capacity, high program attrition, elevated production costs and clinical safety events that may delay development. Some facilities built during the earlier investment cycle have experienced slower order ramp-up than initially expected, encouraging CDMOs to compete through platform processes, shorter timelines, flexible batch sizes and more aggressive commercial terms. AAV also faces inherent limitations involving payload capacity, pre-existing neutralizing antibodies, repeat dosing, high-dose toxicity and tissue-targeting efficiency. Lipid nanoparticles, nonviral delivery and other in vivo gene-editing platforms may therefore substitute for AAV in selected indications. Long-term leadership will depend more on productivity, product quality, successful regulatory filings, commercial supply capability and facility utilization than on nominal installed capacity alone.
This report delivers a comprehensive overview of the global GMP-grade AAV Vector Manufacturing Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GMP-grade AAV Vector Manufacturing Service. The GMP-grade AAV Vector Manufacturing Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GMP-grade AAV Vector Manufacturing Service market comprehensively. Regional market sizes by Type, by Application, by Development Stage, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GMP-grade AAV Vector Manufacturing Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Thermo Fisher Scientific
- Lonza
- Charles River Laboratories
- Catalent
- AGC Biologics
- SK pharmteco
- OXB
- Forge Biologics
- Viralgen
- Andelyn Biosciences
- Resilience
- Advanced Therapies
- IDT Biologika
- Matica Bio
- Takara Bio
- VectorBuilder
- GenScript ProBio
- PackGene Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- GMP Drug Substance Manufacturing
- GMP Drug Substance and Fill-Finish
- End-to-End CMC and Manufacturing
Segment by Application
- Biotechnology Companies
- Pharmaceutical Companies
- Other
Segment by Category
- Early Clinical Manufacturing
- Late-stage Clinical Manufacturing
- PPQ and Commercial Manufacturing
Segment by Division
- Adherent HEK293
- Suspension HEK293
- Baculovirus-Sf9
- Other
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Development Stage, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for GMP-grade AAV Vector Manufacturing Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 GMP Drug Substance Manufacturing
1.2.3 GMP Drug Substance and Fill-Finish
1.2.4 End-to-End CMC and Manufacturing
1.3 Market by Development Stage
1.3.1 Global GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Development Stage: 2021 vs 2025 vs 2032
1.3.2 Early Clinical Manufacturing
1.3.3 Late-stage Clinical Manufacturing
1.3.4 PPQ and Commercial Manufacturing
1.4 Market by Production Platform
1.4.1 Global GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Production Platform: 2021 vs 2025 vs 2032
1.4.2 Adherent HEK293
1.4.3 Suspension HEK293
1.4.4 Baculovirus-Sf9
1.4.5 Other
1.5 Market by Application
1.5.1 Global GMP-grade AAV Vector Manufacturing Service Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global GMP-grade AAV Vector Manufacturing Service Market Perspective (2021–2032)
2.2 Global GMP-grade AAV Vector Manufacturing Service Growth Trends by Region
2.2.1 Global GMP-grade AAV Vector Manufacturing Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 GMP-grade AAV Vector Manufacturing Service Historic Market Size by Region (2021–2026)
2.2.3 GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Region (2027–2032)
2.3 GMP-grade AAV Vector Manufacturing Service Market Dynamics
2.3.1 GMP-grade AAV Vector Manufacturing Service Industry Trends
2.3.2 GMP-grade AAV Vector Manufacturing Service Market Drivers
2.3.3 GMP-grade AAV Vector Manufacturing Service Market Challenges
2.3.4 GMP-grade AAV Vector Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP-grade AAV Vector Manufacturing Service Players by Revenue
3.1.1 Global Top GMP-grade AAV Vector Manufacturing Service Players by Revenue (2021–2026)
3.1.2 Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Players (2021–2026)
3.2 Global Top GMP-grade AAV Vector Manufacturing Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by GMP-grade AAV Vector Manufacturing Service Revenue
3.4 Global GMP-grade AAV Vector Manufacturing Service Market Concentration Ratio
3.4.1 Global GMP-grade AAV Vector Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP-grade AAV Vector Manufacturing Service Revenue in 2025
3.5 Global Key Players of GMP-grade AAV Vector Manufacturing Service Head Offices and Areas Served
3.6 Global Key Players of GMP-grade AAV Vector Manufacturing Service, Products and Applications
3.7 Global Key Players of GMP-grade AAV Vector Manufacturing Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 GMP-grade AAV Vector Manufacturing Service Breakdown Data by Type
4.1 Global GMP-grade AAV Vector Manufacturing Service Historic Market Size by Type (2021–2026)
4.2 Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Type (2027–2032)
5 GMP-grade AAV Vector Manufacturing Service Breakdown Data by Application
5.1 Global GMP-grade AAV Vector Manufacturing Service Historic Market Size by Application (2021–2026)
5.2 Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America GMP-grade AAV Vector Manufacturing Service Market Size (2021–2032)
6.2 North America GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021–2026)
6.4 North America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP-grade AAV Vector Manufacturing Service Market Size (2021–2032)
7.2 Europe GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021–2026)
7.4 Europe GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size (2021–2032)
8.2 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size by Region (2021–2026)
8.4 Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America GMP-grade AAV Vector Manufacturing Service Market Size (2021–2032)
9.2 Latin America GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021–2026)
9.4 Latin America GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size (2021–2032)
10.2 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size by Country (2021–2026)
10.4 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Introduction
11.1.4 Thermo Fisher Scientific Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza GMP-grade AAV Vector Manufacturing Service Introduction
11.2.4 Lonza Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.2.5 Lonza Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Introduction
11.3.4 Charles River Laboratories Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.3.5 Charles River Laboratories Recent Development
11.4 Catalent
11.4.1 Catalent Company Details
11.4.2 Catalent Business Overview
11.4.3 Catalent GMP-grade AAV Vector Manufacturing Service Introduction
11.4.4 Catalent Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.4.5 Catalent Recent Development
11.5 AGC Biologics
11.5.1 AGC Biologics Company Details
11.5.2 AGC Biologics Business Overview
11.5.3 AGC Biologics GMP-grade AAV Vector Manufacturing Service Introduction
11.5.4 AGC Biologics Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.5.5 AGC Biologics Recent Development
11.6 SK pharmteco
11.6.1 SK pharmteco Company Details
11.6.2 SK pharmteco Business Overview
11.6.3 SK pharmteco GMP-grade AAV Vector Manufacturing Service Introduction
11.6.4 SK pharmteco Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.6.5 SK pharmteco Recent Development
11.7 OXB
11.7.1 OXB Company Details
11.7.2 OXB Business Overview
11.7.3 OXB GMP-grade AAV Vector Manufacturing Service Introduction
11.7.4 OXB Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.7.5 OXB Recent Development
11.8 Forge Biologics
11.8.1 Forge Biologics Company Details
11.8.2 Forge Biologics Business Overview
11.8.3 Forge Biologics GMP-grade AAV Vector Manufacturing Service Introduction
11.8.4 Forge Biologics Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.8.5 Forge Biologics Recent Development
11.9 Viralgen
11.9.1 Viralgen Company Details
11.9.2 Viralgen Business Overview
11.9.3 Viralgen GMP-grade AAV Vector Manufacturing Service Introduction
11.9.4 Viralgen Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.9.5 Viralgen Recent Development
11.10 Andelyn Biosciences
11.10.1 Andelyn Biosciences Company Details
11.10.2 Andelyn Biosciences Business Overview
11.10.3 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Introduction
11.10.4 Andelyn Biosciences Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.10.5 Andelyn Biosciences Recent Development
11.11 Resilience
11.11.1 Resilience Company Details
11.11.2 Resilience Business Overview
11.11.3 Resilience GMP-grade AAV Vector Manufacturing Service Introduction
11.11.4 Resilience Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.11.5 Resilience Recent Development
11.12 Advanced Therapies
11.12.1 Advanced Therapies Company Details
11.12.2 Advanced Therapies Business Overview
11.12.3 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Introduction
11.12.4 Advanced Therapies Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.12.5 Advanced Therapies Recent Development
11.13 IDT Biologika
11.13.1 IDT Biologika Company Details
11.13.2 IDT Biologika Business Overview
11.13.3 IDT Biologika GMP-grade AAV Vector Manufacturing Service Introduction
11.13.4 IDT Biologika Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.13.5 IDT Biologika Recent Development
11.14 Matica Bio
11.14.1 Matica Bio Company Details
11.14.2 Matica Bio Business Overview
11.14.3 Matica Bio GMP-grade AAV Vector Manufacturing Service Introduction
11.14.4 Matica Bio Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.14.5 Matica Bio Recent Development
11.15 Takara Bio
11.15.1 Takara Bio Company Details
11.15.2 Takara Bio Business Overview
11.15.3 Takara Bio GMP-grade AAV Vector Manufacturing Service Introduction
11.15.4 Takara Bio Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.15.5 Takara Bio Recent Development
11.16 VectorBuilder
11.16.1 VectorBuilder Company Details
11.16.2 VectorBuilder Business Overview
11.16.3 VectorBuilder GMP-grade AAV Vector Manufacturing Service Introduction
11.16.4 VectorBuilder Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.16.5 VectorBuilder Recent Development
11.17 GenScript ProBio
11.17.1 GenScript ProBio Company Details
11.17.2 GenScript ProBio Business Overview
11.17.3 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Introduction
11.17.4 GenScript ProBio Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.17.5 GenScript ProBio Recent Development
11.18 PackGene Biotech
11.18.1 PackGene Biotech Company Details
11.18.2 PackGene Biotech Business Overview
11.18.3 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Introduction
11.18.4 PackGene Biotech Revenue in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
11.18.5 PackGene Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of GMP Drug Substance Manufacturing
Table 3. Key Players of GMP Drug Substance and Fill-Finish
Table 4. Key Players of End-to-End CMC and Manufacturing
Table 5. Global GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Development Stage (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Early Clinical Manufacturing
Table 7. Key Players of Late-stage Clinical Manufacturing
Table 8. Key Players of PPQ and Commercial Manufacturing
Table 9. Global GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Production Platform (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Adherent HEK293
Table 11. Key Players of Suspension HEK293
Table 12. Key Players of Baculovirus-Sf9
Table 13. Key Players of Other
Table 14. Global GMP-grade AAV Vector Manufacturing Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global GMP-grade AAV Vector Manufacturing Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global GMP-grade AAV Vector Manufacturing Service Market Size by Region (US$ Million), 2021–2026
Table 17. Global GMP-grade AAV Vector Manufacturing Service Market Share by Region (2021–2026)
Table 18. Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 19. Global GMP-grade AAV Vector Manufacturing Service Market Share by Region (2027–2032)
Table 20. GMP-grade AAV Vector Manufacturing Service Market Trends
Table 21. GMP-grade AAV Vector Manufacturing Service Market Drivers
Table 22. GMP-grade AAV Vector Manufacturing Service Market Challenges
Table 23. GMP-grade AAV Vector Manufacturing Service Market Restraints
Table 24. Global GMP-grade AAV Vector Manufacturing Service Revenue by Players (US$ Million), 2021–2026
Table 25. Global GMP-grade AAV Vector Manufacturing Service Market Share by Players (2021–2026)
Table 26. Global Top GMP-grade AAV Vector Manufacturing Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on GMP-grade AAV Vector Manufacturing Service Revenue, 2025
Table 27. Ranking of Global Top GMP-grade AAV Vector Manufacturing Service Companies by Revenue (US$ Million) in 2025
Table 28. Global 5 Largest Players Market Share by GMP-grade AAV Vector Manufacturing Service Revenue (CR5 and HHI), 2021–2026
Table 29. Global Key Players of GMP-grade AAV Vector Manufacturing Service, Headquarters and Area Served
Table 30. Global Key Players of GMP-grade AAV Vector Manufacturing Service, Products and Applications
Table 31. Global Key Players of GMP-grade AAV Vector Manufacturing Service, Date of General Availability (GA)
Table 32. Mergers and Acquisitions, Expansion Plans
Table 33. Global GMP-grade AAV Vector Manufacturing Service Market Size by Type (US$ Million), 2021–2026
Table 34. Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Type (2021–2026)
Table 35. Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 36. Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Type (2027–2032)
Table 37. Global GMP-grade AAV Vector Manufacturing Service Market Size by Application (US$ Million), 2021–2026
Table 38. Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Application (2021–2026)
Table 39. Global GMP-grade AAV Vector Manufacturing Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 40. Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Application (2027–2032)
Table 41. North America GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. North America GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 43. North America GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 44. Europe GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Europe GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 46. Europe GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 47. Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 48. Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size by Region (US$ Million), 2021–2026
Table 49. Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size by Region (US$ Million), 2027–2032
Table 50. Latin America GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Latin America GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 52. Latin America GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 53. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2021–2026
Table 55. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size by Country (US$ Million), 2027–2032
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Product
Table 59. Thermo Fisher Scientific Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza GMP-grade AAV Vector Manufacturing Service Product
Table 64. Lonza Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 65. Lonza Recent Development
Table 66. Charles River Laboratories Company Details
Table 67. Charles River Laboratories Business Overview
Table 68. Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Product
Table 69. Charles River Laboratories Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 70. Charles River Laboratories Recent Development
Table 71. Catalent Company Details
Table 72. Catalent Business Overview
Table 73. Catalent GMP-grade AAV Vector Manufacturing Service Product
Table 74. Catalent Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 75. Catalent Recent Development
Table 76. AGC Biologics Company Details
Table 77. AGC Biologics Business Overview
Table 78. AGC Biologics GMP-grade AAV Vector Manufacturing Service Product
Table 79. AGC Biologics Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 80. AGC Biologics Recent Development
Table 81. SK pharmteco Company Details
Table 82. SK pharmteco Business Overview
Table 83. SK pharmteco GMP-grade AAV Vector Manufacturing Service Product
Table 84. SK pharmteco Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 85. SK pharmteco Recent Development
Table 86. OXB Company Details
Table 87. OXB Business Overview
Table 88. OXB GMP-grade AAV Vector Manufacturing Service Product
Table 89. OXB Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 90. OXB Recent Development
Table 91. Forge Biologics Company Details
Table 92. Forge Biologics Business Overview
Table 93. Forge Biologics GMP-grade AAV Vector Manufacturing Service Product
Table 94. Forge Biologics Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 95. Forge Biologics Recent Development
Table 96. Viralgen Company Details
Table 97. Viralgen Business Overview
Table 98. Viralgen GMP-grade AAV Vector Manufacturing Service Product
Table 99. Viralgen Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 100. Viralgen Recent Development
Table 101. Andelyn Biosciences Company Details
Table 102. Andelyn Biosciences Business Overview
Table 103. Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Product
Table 104. Andelyn Biosciences Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 105. Andelyn Biosciences Recent Development
Table 106. Resilience Company Details
Table 107. Resilience Business Overview
Table 108. Resilience GMP-grade AAV Vector Manufacturing Service Product
Table 109. Resilience Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 110. Resilience Recent Development
Table 111. Advanced Therapies Company Details
Table 112. Advanced Therapies Business Overview
Table 113. Advanced Therapies GMP-grade AAV Vector Manufacturing Service Product
Table 114. Advanced Therapies Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 115. Advanced Therapies Recent Development
Table 116. IDT Biologika Company Details
Table 117. IDT Biologika Business Overview
Table 118. IDT Biologika GMP-grade AAV Vector Manufacturing Service Product
Table 119. IDT Biologika Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 120. IDT Biologika Recent Development
Table 121. Matica Bio Company Details
Table 122. Matica Bio Business Overview
Table 123. Matica Bio GMP-grade AAV Vector Manufacturing Service Product
Table 124. Matica Bio Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 125. Matica Bio Recent Development
Table 126. Takara Bio Company Details
Table 127. Takara Bio Business Overview
Table 128. Takara Bio GMP-grade AAV Vector Manufacturing Service Product
Table 129. Takara Bio Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 130. Takara Bio Recent Development
Table 131. VectorBuilder Company Details
Table 132. VectorBuilder Business Overview
Table 133. VectorBuilder GMP-grade AAV Vector Manufacturing Service Product
Table 134. VectorBuilder Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 135. VectorBuilder Recent Development
Table 136. GenScript ProBio Company Details
Table 137. GenScript ProBio Business Overview
Table 138. GenScript ProBio GMP-grade AAV Vector Manufacturing Service Product
Table 139. GenScript ProBio Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 140. GenScript ProBio Recent Development
Table 141. PackGene Biotech Company Details
Table 142. PackGene Biotech Business Overview
Table 143. PackGene Biotech GMP-grade AAV Vector Manufacturing Service Product
Table 144. PackGene Biotech Revenue in GMP-grade AAV Vector Manufacturing Service Business (US$ Million), 2021–2026
Table 145. PackGene Biotech Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. GMP-grade AAV Vector Manufacturing Service Picture
Figure 2. Global GMP-grade AAV Vector Manufacturing Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global GMP-grade AAV Vector Manufacturing Service Market Share by Type: 2025 vs 2032
Figure 4. GMP Drug Substance Manufacturing Features
Figure 5. GMP Drug Substance and Fill-Finish Features
Figure 6. End-to-End CMC and Manufacturing Features
Figure 7. Global GMP-grade AAV Vector Manufacturing Service Market Size Comparison by Development Stage (US$ Million), 2021–2032
Figure 8. Early Clinical Manufacturing Features
Figure 9. Late-stage Clinical Manufacturing Features
Figure 10. PPQ and Commercial Manufacturing Features
Figure 11. Global GMP-grade AAV Vector Manufacturing Service Market Size Comparison by Production Platform (US$ Million), 2021–2032
Figure 12. Adherent HEK293 Features
Figure 13. Suspension HEK293 Features
Figure 14. Baculovirus-Sf9 Features
Figure 15. Other Features
Figure 16. Global GMP-grade AAV Vector Manufacturing Service Market Size by Application (US$ Million), 2021–2032
Figure 17. Global GMP-grade AAV Vector Manufacturing Service Market Share by Application: 2025 vs 2032
Figure 18. Biotechnology Companies Case Studies
Figure 19. Pharmaceutical Companies Case Studies
Figure 20. Other Case Studies
Figure 21. GMP-grade AAV Vector Manufacturing Service Report Years Considered
Figure 22. Global GMP-grade AAV Vector Manufacturing Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 23. Global GMP-grade AAV Vector Manufacturing Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global GMP-grade AAV Vector Manufacturing Service Market Share by Region: 2025 vs 2032
Figure 25. Global GMP-grade AAV Vector Manufacturing Service Market Share by Players in 2025
Figure 26. Global GMP-grade AAV Vector Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by GMP-grade AAV Vector Manufacturing Service Revenue in 2025
Figure 28. North America GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. North America GMP-grade AAV Vector Manufacturing Service Market Share by Country (2021–2032)
Figure 30. United States GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Canada GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe GMP-grade AAV Vector Manufacturing Service Market Share by Country (2021–2032)
Figure 34. Germany GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. France GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. U.K. GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Italy GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Russia GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Ireland GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific GMP-grade AAV Vector Manufacturing Service Market Share by Region (2021–2032)
Figure 42. China GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Japan GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. South Korea GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Southeast Asia GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. India GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Australia & New Zealand GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America GMP-grade AAV Vector Manufacturing Service Market Share by Country (2021–2032)
Figure 50. Mexico GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Brazil GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Market Share by Country (2021–2032)
Figure 54. Israel GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Saudi Arabia GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. UAE GMP-grade AAV Vector Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 58. Lonza Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 59. Charles River Laboratories Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 60. Catalent Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 61. AGC Biologics Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 62. SK pharmteco Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 63. OXB Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 64. Forge Biologics Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 65. Viralgen Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 66. Andelyn Biosciences Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 67. Resilience Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 68. Advanced Therapies Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 69. IDT Biologika Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 70. Matica Bio Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 71. Takara Bio Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 72. VectorBuilder Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 73. GenScript ProBio Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 74. PackGene Biotech Revenue Growth Rate in GMP-grade AAV Vector Manufacturing Service Business (2021–2026)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global GMP-grade AAV Vector Manufacturing Service market?
The top companies in the global GMP-grade AAV Vector Manufacturing Service market are Thermo Fisher Scientific、Lonza、Charles River Laboratories.
What was the global market size of GMP-grade AAV Vector Manufacturing Service in 2026?
What was the global market size of GMP-grade AAV Vector Manufacturing Service in 2032?
What is the annual compound growth rate of the global GMP-grade AAV Vector Manufacturing Service market size from 2026 to 2032?
Which region is expected to have the highest market share?
Related Reports
GMP-grade AAV Vector Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for GMP-grade AAV Vector Manufacturing Service was estimated to be worth US$ 865 million in 2025 and is projected to reach US$ 2060 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 124
USD 3950.00
(Single User License)
Global GMP-grade AAV Vector Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global GMP-grade AAV Vector Manufacturing Service market is projected to grow from US$ 865 million in 2025 to US$ 2060 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 148
USD 4900.00
(Single User License)
Global GMP-grade AAV Vector Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global GMP-grade AAV Vector Manufacturing Service market size was US$ 865 million in 2025 and is forecast to reach a readjusted size of US$ 2060 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 132
USD 4250.00
(Single User License)
GMP-grade AAV Vector Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for GMP-grade AAV Vector Manufacturing Service was estimated to be worth US$ 865 million in 2025 and is projected to reach US$ 2060 million, growing at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-07-18
Pages: 124
USD 3950.00 (Single User License)Global GMP-grade AAV Vector Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global GMP-grade AAV Vector Manufacturing Service market is projected to grow from US$ 865 million in 2025 to US$ 2060 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 148
USD 4900.00 (Single User License)Global GMP-grade AAV Vector Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global GMP-grade AAV Vector Manufacturing Service market size was US$ 865 million in 2025 and is forecast to reach a readjusted size of US$ 2060 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 132
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now